Dynavax Technologies Overview
Company Headquarters: California, US
Founded: 1996
Workforce: ~351
Company Working: Dynavax Technologies is a commercial-stage biopharmaceutical business with extensive experience and skill in vaccine development and commercialization. The company has established several clinical and preclinical collaborations with vaccine developers to evaluate vaccine product candidates against influenza, other infectious diseases, and particularly COVID-19 across a variety of vaccine platforms. It is focused on building an innovative pipeline of investigational vaccine product candidates, leveraging its proven, proprietary vaccine adjuvant technology



